A promising HIV vaccine candidate demonstrated its power by neutralizing HIV strains in mice, guinea pigs and monkeys, and is almost ready for human testing. The findings were published on June 4th in the journal Nature Medicine, and it was led by investigators from the National Institute of Allergy and Infectious Diseases, which falls under the National Institutes of Health. Chief of the Structural Biology Section at the NIAID Vaccine Research Center Peter D. Kwong, Ph.D and John R. Mascola, M.D., center director, spearheaded...
- Upcoming Events
- Contact Us